Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia

Addiction

Volumn 105, Issue 6, 2010, Pages 1055-1061

  Wisaksana, Rudi ^a,c   Indrati, Agnes K ^a,c   Fibriani, Azzania ^a,c   Rogayah, Ega ^a,c   Sudjana, Primal ^a   Djajakusumah, Tony S ^a   Sumantri, Rachmat ^a   Alisjahbana, Bachti ^a,c   Van Der Ven, Andre ^b   Van Crevel, Reinout ^b,c  

^a BANDUNG INSTITUTE OF TECHNOLOGY   (Indonesia)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c PADJADJARAN UNIVERSITY   (Indonesia)

Author keywords

Antiretroviral therapy; Highly active; HIV infections; Indonesia; Intravenous; Substance abuse; Treatment outcome

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; FEMALE; HEALTH CARE DELIVERY; HEALTH PERSONNEL ATTITUDE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDONESIA; KAPLAN MEIER METHOD; MALE; MORTALITY; PATIENT; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; SUBSTANCE ABUSE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEPATITIS C; HIV INFECTIONS; HUMANS; INDONESIA; KAPLAN-MEIER ESTIMATE; MALE; MEDICATION ADHERENCE; PATIENT DROPOUTS; RETROSPECTIVE STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; TREATMENT OUTCOME;

EID: 77951994063     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.02898.x     Document Type: Article

References (28)

1. Pisani E., Garnett G. P., Brown T., Stover J., Grassly N. C., Hankins C. et al. Back to basics in HIV prevention: focus on exposure. BMJ 2003 326 : 1384 1387. (Pubitemid 36751041)
2. Joint United Nations Programme on HIV/AIDS (UNAIDS). Report on the Global AIDS Epidemic 2008.
3. Wood E., Kerr T., Tyndall M. W., Montaner J. S. A review of barriers and facilitators of HIV treatment among injection drug users. AIDS 2008 22 : 1247 1256. (Pubitemid 351354521)
4. Paxton S., Gonzales G., Uppakaew K., Abraham K. K., Okta S., Green C. et al. AIDS-related discrimination in Asia. AIDS Care 2005 17 : 413 424. (Pubitemid 40663200)
5. Merati T., Supriyadi, Yuliana F. The disjunction between policy and practice: HIV discrimination in health care and employment in Indonesia. AIDS Care 2005 17 : S175 9. (Pubitemid 41499302)
6. Roux P., Carrieri M. P., Villes V., Dellamonica P., Poizot-Martin I., Ravaux I. et al. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study. Addiction 2008 103 : 1828 1836.
7. Donoghoe M. C., Bollerup A. R., Lazarus J. V., Nielsen S., Matic S. Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002-2004. Int J Drug Policy 2007 18 : 271 280. (Pubitemid 47126280)
8. Bouhnik A. D., Chesney M., Carrieri P., Gallais H., Moreau J., Moatti J. P. et al. Nonadherence among HIV-infected injecting drug users: the impact of social instability. J Acquir Immune Defic Syndr 2002 31 : S149 53. (Pubitemid 35453577)
9. World Health Organization (WHO). Antiretroviral Therapy for HIV Infection in Adults and Adolescents in Resources-Limited Settings: Toward Universal Access.
10. Lincoln D., Petoumenos K., Dore G. J. HIV/HBV and HIV/HCV co infection and outcomes following highly active antiretroviral therapy. HIV Med 2003 4 : 241 249. (Pubitemid 36949880)
11. Celentano D. D., Galai N., Sethi A. K., Shah N. G., Strathdee S. A., Vlahov D. et al. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS 2001 15 : 1707 1715. (Pubitemid 32918126)
12. Aceijas C., Oppenheimer E., Stimson G. V., Ashcroft R. E., Matic S., Hickman M. Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the 'Treating 3 million by 2005. Making it happen. The WHO strategy' ('3 by 5'). Addiction 101 : 1246 1253.
13. Lert F., Kazatchkine M. D. Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview. Int J Drug Policy 2007 18 : 255 261. (Pubitemid 47126282)
14. Wood E., Hogg R. S., Lima V. D., Kerr T., Yip B., Marshall B. D. et al. Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA 2008 300 : 550 554.
15. Wood E., Hogg R. S., Yip B., Dong W. W., Wynhoven B., Mo T. et al. Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use. AIDS 2005 19 : 1189 1195. (Pubitemid 41059260)
16. Chesney M. A., Ickovics J. R., Chambers D. B., Gifford A. L., Neidig J., Zwickl B. et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000 12 : 255 266.
17. Calmy A., Pinoges L., Szumilin E., Zachariah R., Ford N., Ferradini L. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS 2006 20 : 1163 1169. (Pubitemid 43786105)
18. Dabis F., Balestre E., Braitstein P., Miotti P., Brinkhof W. G., Schneider M. et al. Cohort profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts. Int J Epidemiol 2005 34 : 979 986. (Pubitemid 41535538)
19. Zhou J., Dore G. J., Zhang F., Lim P. L., Chen Y. M. Hepatitis B and C virus coinfection in the TREAT Asia HIV observational database. J Gastroenterol Hepatol 2007 22 : 1510 1518. (Pubitemid 47274591)
20. Calmy A., Klement E., Teck R., Berman D., Pecoul B., Ferradini L. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up. AIDS 2004 18 : 2353 2360. (Pubitemid 40065902)
21. Ferradini L., Laureillard D., Prak N., Ngeth C., Fernandez M., Pinoges L. et al. Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia. AIDS 2007 21 : 2293 2301. (Pubitemid 350287455)
22. Madec Y., Laureillard D., Pinoges L., Fernandez M., Prak N., Ngeth C. et al. Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia. AIDS 2007 21 : 351 359. (Pubitemid 46175047)
23. Braitstein P., Brinkhof M. W., Dabis F., Schechter M., Boulle A., Miotti P. et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006 367 : 817 824.
24. World Health Organization ROfS-EA. Review of the Health Sector Response to HIV and AIDS in Indonesia 2007.
25. Lawn S. D., Harries A. D., Anglaret X., Myer L., Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008 22 : 1897 1908.
26. Rosen S., Fox M. P., Gill C. J. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 2007 4 : e298. (Pubitemid 350035458)
27. Yu J. K., Chen S. C., Wang K. Y., Chang C. S., Makombe S. D., Schouten E. J. et al. True outcomes for patients on antiretroviral therapy who are 'lost to follow-up' in Malawi. Bull World Health Organ 2007 85 : 550 554. (Pubitemid 47041634)
28. Akbar N., Basuki B., Mulyanto, Garabrant D. H., Sulaiman A., Noer H. M. Ethnicity, socioeconomic status, transfusions and risk of hepatitis B and hepatitis C infection. J Gastroenterol Hepatol 1997 12 : 752 757. (Pubitemid 27512808)